Rep. Kevin Hern Sells Off Organon & Co. (NYSE:OGN) Shares

Posted by Stanley Muller on Aug 13th, 2026

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Organon & Co. (NYSE:OGN). In a filing disclosed on August 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Organon & Co. stock on August 5th. The trade occurred in the Representative’s “HERN FAMILY FOUNDATION” account.

Representative Kevin Hern also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Diageo (NYSE:DEO) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Estee Lauder Companies (NYSE:EL) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Mondelez International (NASDAQ:MDLZ) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Versant (NASDAQ:VSNT) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Comcast (NASDAQ:CMCSA) on 8/5/2026.
Sold $1,001 – $15,000 in shares of Kenvue (NYSE:KVUE) on 8/5/2026.

Organon & Co. Price Performance

Organon & Co. stock opened at $13.66 on Thursday. Organon & Co. has a 12 month low of $5.69 and a 12 month high of $13.70. The company has a debt-to-equity ratio of 8.43, a current ratio of 1.95 and a quick ratio of 1.44. The business has a 50 day simple moving average of $13.51 and a 200-day simple moving average of $10.68. The stock has a market capitalization of $3.59 billion, a PE ratio of 17.74, a price-to-earnings-growth ratio of 1.26 and a beta of 1.55.

Organon & Co. Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 10th. Stockholders of record on Friday, August 14th will be issued a $0.02 dividend. The ex-dividend date of this dividend is Friday, August 14th. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.6%. Organon & Co.’s payout ratio is presently 10.39%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of OGN. Allied Private Wealth LLC purchased a new stake in shares of Organon & Co. during the 2nd quarter worth $33,000. Farther Finance Advisors LLC increased its holdings in shares of Organon & Co. by 87.8% in the 4th quarter. Farther Finance Advisors LLC now owns 4,349 shares of the company’s stock valued at $31,000 after purchasing an additional 2,033 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Organon & Co. by 69.8% in the second quarter. GAMMA Investing LLC now owns 5,782 shares of the company’s stock valued at $78,000 after purchasing an additional 2,376 shares during the period. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Organon & Co. in the fourth quarter valued at about $44,000. Finally, Kestra Advisory Services LLC purchased a new stake in Organon & Co. during the fourth quarter worth about $47,000. Institutional investors and hedge funds own 77.43% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on OGN shares. BNP Paribas Exane reissued a “neutral” rating and issued a $14.00 price objective (up from $12.00) on shares of Organon & Co. in a research note on Wednesday, April 29th. Piper Sandler raised shares of Organon & Co. from an “underweight” rating to a “neutral” rating and lifted their target price for the company from $5.00 to $14.00 in a report on Tuesday, April 28th. Finally, Weiss Ratings lowered shares of Organon & Co. from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, August 3rd. Five research analysts have rated the stock with a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $11.40.

Get Our Latest Report on Organon & Co.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About Organon & Co.

(Get Free Report)

Organon & Co is a global healthcare company that was established as an independent, publicly traded entity following its spin-off from Merck & Co in June 2021. Headquartered in Jersey City, New Jersey, Organon focuses on delivering therapeutic solutions across women’s health, biosimilars, and established brands. The company’s creation reflected a strategic effort to concentrate on specialty pharmaceuticals and legacy products with proven patient impact.

In women’s health, Organon provides a broad portfolio of products addressing reproductive and gynecological conditions, including fertility treatments, contraception, and hormone replacement therapies.